Renowned Vaccine Scientist Dr. Stanley Plotkin to Help Guide Inovio’s Efforts to Develop Preventive and Therapeutic DNA Vaccines

Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that Stanley A. Plotkin, MD, has agreed to join the company’s scientific advisory board.

Dr. Plotkin developed the rubella vaccine now used worldwide and has worked extensively on the development and application of other vaccines including polio, rabies, varicella, rotavirus and cytomegalovirus. He is Emeritus Professor, Wistar Institute and the University of Pennsylvania, and Executive Advisor to the CEO of Sanofi Pasteur.

Over the course of his career he has served as senior assistant surgeon with the Epidemic Intelligence Service, U.S. Public Health Service; director of the Division of Infectious Diseases at Children’s Hospital of Philadelphia; associate chairman of the Department of Pediatrics, University of Pennsylvania; and medical and scientific director of Aventis Pasteur.

Dr. Plotkin’s professional awards include the Sabin Foundation Medal (2002); the French Legion Medal of Honor (1998); the Clinical Virology Award, Pan American Group for Rapid Viral Diagnosis (1995); the Distinguished Physician Award, Pediatric Infectious Disease Society (1993); and the Bruce Medal of the American College of Physicians (1987).

Dr. J. Joseph Kim, Inovio’s CEO, stated, “Dr. Plotkin is an internationally renowned virologist who has made significant contributions to the goal of conquering diseases with vaccines. We are honored to have Dr Plotkin join our distinguished panel of scientific advisors, who are committed to helping guide Inovio’s development of DNA vaccines, a potentially vital new generation of vaccines targeting cancers and chronic infectious diseases.”

Dr. Plotkin joins Dr. David B. Weiner and Dr. Robert S. Langer on Inovio's Scientific Advisory Board. Dr. Weiner is Chairman of the Scientific Advisory Board and is a professor of the Department of Pathology & Laboratory Medicine, University of Pennsylvania. Dr. Weiner is considered to be a pioneer of the field of DNA vaccines. Dr. Langer, Germeshausen Professor of Chemical and Biomedical Engineering at the Massachusetts Institute of Technology, is a renowned scientist with numerous distinguished awards. Drs. Weiner and Langer have both advised organizations such as the FDA and multiple life sciences companies. Both Drs.